(Adnkronos) - “Ciò che è ancora più interessante è che si parlerà sempre più di una vaccinazione terapeutica, visto il largo impiego che troverà questa tecnologia - mRna - di fronte alla cura di tante malattie, che per ora non hanno una cura specifica”. Sono le parole di Giuseppe Palmisano, segretario generale provinciale Fimmg, Federazione italiana medicina generale di Venezia intervenendo all’expert advisory panel sull'innovazione della tecnologia mRna.
Category
🗞
NewsTranscript
00:00What is the role of the National Vaccination Plan?
00:04The National Vaccination Plan sees fundamental actors for the organization and implementation of this new technology.
00:18For years now, family doctors have been ready to face the various vaccination campaigns
00:26through the historical implementation of an organized vaccination school, both at the union level and at the level of scientific societies.
00:36Therefore, as a category, this new technology also sees us a bit at the forefront.
00:42It is about continuing in the training process of individual colleagues, making them increasingly aware of these potentials.
00:52It is also about dedicating time and attention.
00:57In this case, we are also talking about tailor-made medicine,
01:03because for each patient the most appropriate vaccine will be defined at the time of the vaccination campaigns.
01:12And the most interesting thing is that we will talk more and more about therapeutic vaccination,
01:20given the wide use that this technology will find in the treatment of so many diseases that do not yet have a specific cure.